Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

doi:10.1084/jem.179.4.1379

This Article

	Full Text (PDF, 1377K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Wogensen, L.
	Articles by Sarvetnick, N.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Wogensen, L.
	Articles by Sarvetnick, N.


Social Bookmarking

	What's this?

ARTICLES

Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

L Wogensen, MS Lee and N Sarvetnick
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037.

The T helper type 2 (Th2) cell product interleukin 10 (IL-10) inhibits the proliferation and function of Th1 lymphocytes and macrophages (M phi). The nonobese diabetic mouse strain (NOD/Shi) develops a M phi and T cell-dependent autoimmune diabetes that closely resembles human insulin-dependent diabetes mellitus (IDDM). The objective of the present study was to explore the consequences of localized production of IL-10 on diabetes development in NOD/Shi mice. Surprisingly, local production of IL-10 accelerated the onset and increased the prevalence of diabetes, since diabetes developed at 5-10 wk of age in 92% of IL-10 positive I-A beta g7/g7, I-E- mice in first (N2) and second (N3) generation backcrosses between IL-10 transgenic BALB/c mice and (NOD/Shi) mice. None of the IL-10 negative major histocompatibility complex-identical littermates were diabetic at this age. Furthermore, diabetes developed in 33% of I-A beta g7/d, I-E+ N3 mice in the presence of IL-10 before the mice were 10 wk old. Our findings support the notion that IL-10 should not simply be regarded as an immunoinhibitory cytokine, since it possesses powerful, immunostimulatory properties as well. Furthermore, our observations suggest that beta cell destruction in NOD mice may be a Th2-mediated event.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Robson, N. C., Phillips, D. J., McAlpine, T., Shin, A., Svobodova, S., Toy, T., Pillay, V., Kirkpatrick, N., Zanker, D., Wilson, K., Helling, I., Wei, H., Chen, W., Cebon, J., Maraskovsky, E. (2008). Activin-A: a novel dendritic cell-derived cytokine that potently attenuates CD40 ligand-specific cytokine and chemokine production. Blood 111: 2733-2743 [Abstract] [Full Text]
Battaglia, M., Stabilini, A., Draghici, E., Migliavacca, B., Gregori, S., Bonifacio, E., Roncarolo, M.-G. (2006). Induction of Tolerance in Type 1 Diabetes via Both CD4+CD25+ T Regulatory Cells and T Regulatory Type 1 Cells. Diabetes 55: 1571-1580 [Abstract] [Full Text]
Battaglia, M., Stabilini, A., Draghici, E., Gregori, S., Mocchetti, C., Bonifacio, E., Roncarolo, M.-G. (2006). Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance. Diabetes 55: 40-49 [Abstract] [Full Text]
Chen, H., Li, X., Epstein, P. N. (2005). MnSOD and Catalase Transgenes Demonstrate That Protection of Islets From Oxidative Stress Does Not Alter Cytokine Toxicity. Diabetes 54: 1437-1446 [Abstract] [Full Text]
Gregg, R. K., Bell, J. J., Lee, H.-H., Jain, R., Schoenleber, S. J., Divekar, R., Zaghouani, H. (2005). IL-10 Diminishes CTLA-4 Expression on Islet-Resident T Cells and Sustains Their Activation Rather Than Tolerance. J. Immunol. 174: 662-670 [Abstract] [Full Text]
Goudy, K. S., Burkhardt, B. R., Wasserfall, C., Song, S., Campbell-Thompson, M. L., Brusko, T., Powers, M. A., Clare-Salzler, M. J., Sobel, E. S., Ellis, T. M., Flotte, T. R., Atkinson, M. A. (2003). Systemic Overexpression of IL-10 Induces CD4+CD25+ Cell Populations In Vivo and Ameliorates Type 1 Diabetes in Nonobese Diabetic Mice in a Dose-Dependent Fashion. J. Immunol. 171: 2270-2278 [Abstract] [Full Text]
Zhang, Y. C., Pileggi, A., Agarwal, A., Molano, R. D., Powers, M., Brusko, T., Wasserfall, C., Goudy, K., Zahr, E., Poggioli, R., Scott-Jorgensen, M., Campbell-Thompson, M., Crawford, J. M., Nick, H., Flotte, T., Ellis, T. M., Ricordi, C., Inverardi, L., Atkinson, M. A. (2003). Adeno-Associated Virus-Mediated IL-10 Gene Therapy Inhibits Diabetes Recurrence in Syngeneic Islet Cell Transplantation of NOD Mice. Diabetes 52: 708-716 [Abstract] [Full Text]
Koarada, S., Wu, Y., Olshansky, G., Ridgway, W. M. (2002). Increased Nonobese Diabetic Th1:Th2 (IFN-{gamma}:IL-4) Ratio Is CD4+ T Cell Intrinsic and Independent of APC Genetic Background. J. Immunol. 169: 6580-6587 [Abstract] [Full Text]
Lee, C. G., Homer, R. J., Cohn, L., Link, H., Jung, S., Craft, J. E., Graham, B. S., Johnson, T. R., Elias, J. A. (2002). Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways. J. Biol. Chem. 277: 35466-35474 [Abstract] [Full Text]
Rosenblum, I Y, Dayan, A D (2002). Carcinogenicity testing of IL-10: principles and practicalities. Hum Exp Toxicol 21: 347-358 [Abstract]
Cha, S., Peck, A.B., Humphreys-Beher, M.G. (2002). PROGRESS IN UNDERSTANDING AUTOIMMUNE EXOCRINOPATHY USING THE NON-OBESE DIABETIC MOUSE: AN UPDATE. Crit. Rev. Oral Biol. Med. 13: 5-16 [Abstract] [Full Text]
Cha, S., Peck, A.B., Humphreys-Beher, M.G. (2002). PROGRESS IN UNDERSTANDING AUTOIMMUNE EXOCRINOPATHY USING THE NON-OBESE DIABETIC MOUSE: AN UPDATE. fake Crit Rev Oral Biol Med 13: 5-16 [Abstract] [Full Text]
Phillips, J. M., Parish, N. M., Drage, M., Cooke, A. (2001). Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes. J. Immunol. 167: 6087-6091 [Abstract] [Full Text]
Goudy, K., Song, S., Wasserfall, C., Zhang, Y. C., Kapturczak, M., Muir, A., Powers, M., Scott-Jorgensen, M., Campbell-Thompson, M., Crawford, J. M., Ellis, T. M., Flotte, T. R., Atkinson, M. A. (2001). Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc. Natl. Acad. Sci. USA 98: 13913-13918 [Abstract] [Full Text]
Johansson, A. C. M., Hansson, A.-S., Nandakumar, K. S., Backlund, J., Holmdahl, R. (2001). IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies. J. Immunol. 167: 3505-3512 [Abstract] [Full Text]
Chen, H., Carlson, E. C., Pellet, L., Moritz, J. T., Epstein, P. N. (2001). Overexpression of Metallothionein in Pancreatic {beta}-Cells Reduces Streptozotocin-Induced DNA Damage and Diabetes. Diabetes 50: 2040-2046 [Abstract] [Full Text]
Koarada, S., Wu, Y., Ridgway, W. M. (2001). Increased Entry into the IFN-{gamma} Effector Pathway by CD4+ T Cells Selected by I-Ag7 on a Nonobese Diabetic Versus C57BL/6 Genetic Background. J. Immunol. 167: 1693-1702 [Abstract] [Full Text]
La Cava, A., Balasa, B., Good, A., van Gunst, K., Jung, N., Sarvetnick, N. (2001). H-2D End Confers Dominant Protection from IL-10-Mediated Acceleration of Autoimmune Diabetes in the Nonobese Diabetic Mouse. J. Immunol. 167: 1066-1071 [Abstract] [Full Text]
Slavin, A. J., Maron, R., Weiner, H. L. (2001). Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol 13: 825-833 [Abstract] [Full Text]
Kawamoto, S., Nitta, Y., Tashiro, F., Nakano, A., Yamato, E., Tahara, H., Tabayashi, K., Miyazaki, J.-i. (2001). Suppression of Th1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10. Int Immunol 13: 685-694 [Abstract] [Full Text]
Ostlie, N. S., Karachunski, P. I., Wang, W., Monfardini, C., Kronenberg, M., Conti-Fine, B. M. (2001). Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis. J. Immunol. 166: 4853-4862 [Abstract] [Full Text]
Croxford, J. L., Feldmann, M., Chernajovsky, Y., Baker, D. (2001). Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System. J. Immunol. 166: 4124-4130 [Abstract] [Full Text]
Chen, Y., Rosloniec, E., Goral, M. I., Boothby, M., Chen, J. (2001). Redirection of T Cell Effector Function In Vivo and Enhanced Collagen-Induced Arthritis Mediated by an IL-2R{{beta}}/IL-4R{{alpha}} Chimeric Cytokine Receptor Transgene. J. Immunol. 166: 4163-4169 [Abstract] [Full Text]
Qin, L., Ding, Y., Tahara, H., Bromberg, J. S. (2001). Viral IL-10-Induced Immunosuppression Requires Th2 Cytokines and Impairs APC Function Within the Allograft. J. Immunol. 166: 2385-2393 [Abstract] [Full Text]
Serreze, D. V., Chapman, H. D., Post, C. M., Johnson, E. A., Suarez-Pinzon, W. L., Rabinovitch, A. (2001). Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation. J. Immunol. 166: 1352-1359 [Abstract] [Full Text]
Balasa, B., La Cava, A., Van Gunst, K., Mocnik, L., Balakrishna, D., Nguyen, N., Tucker, L., Sarvetnick, N. (2000). A Mechanism for IL-10-Mediated Diabetes in the Nonobese Diabetic (NOD) Mouse: ICAM-1 Deficiency Blocks Accelerated Diabetes. J. Immunol. 165: 7330-7337 [Abstract] [Full Text]
Balasa, B., Van Gunst, K., Jung, N., Balakrishna, D., Santamaria, P., Hanafusa, T., Itoh, N., Sarvetnick, N. (2000). Islet-Specific Expression of IL-10 Promotes Diabetes in Nonobese Diabetic Mice Independent of Fas, Perforin, TNF Receptor-1, and TNF Receptor-2 Molecules. J. Immunol. 165: 2841-2849 [Abstract] [Full Text]
Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S., Roman, J. J., Parham, G. P., Cannon, M. J. (2000). Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes. J. Virol. 74: 4729-4737 [Abstract] [Full Text]
Papaccio, G., Nicoletti, F., Aurelio Pisanti, F., Bendtzen, K., galdieri, M. (2000). Prevention of Spontaneous Autoimmune Diabetes in NOD Mice by Transferring in Vitro Antigen-Pulsed Syngeneic Dendritic Cells. Endocrinology 141: 1500-1505 [Abstract] [Full Text]
van Scott, M. R., Justice, J. P., Bradfield, J. F., Enright, E., Sigounas, A., Sur, S. (2000). IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 278: L667-L674 [Abstract] [Full Text]
Lepault, F., Gagnerault, M. C. (2000). Characterization of Peripheral Regulatory CD4+ T Cells That Prevent Diabetes Onset in Nonobese Diabetic Mice. J. Immunol. 164: 240-247 [Abstract] [Full Text]
Azar, S. T., Tamim, H., Beyhum, H. N., Habbal, M. Z., Almawi, W. Y. (1999). Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease. CVI 6: 306-310 [Full Text]
Almawi, W. Y., Tamim, H., Azar, S. T. (1999). T Helper Type 1 and 2 Cytokines Mediate the Onset and Progression of Type I (Insulin-Dependent) Diabetes. J. Clin. Endocrinol. Metab. 84: 1497-1502 [Abstract] [Full Text]
Adib-Conquy, M., Petit, A.-F., Marie, C., Fitting, C., Cavaillon, J.-M. (1999). Paradoxical priming effects of IL-10 on cytokine production. Int Immunol 11: 689-698 [Abstract] [Full Text]
Saito, I., Haruta, K., Shimuta, M., Inoue, H., Sakurai, H., Yamada, K., Ishimaru, N., Higashiyama, H., Sumida, T., Ishida, H., Suda, T., Noda, T., Hayashi, Y., Tsubota, K. (1999). Fas Ligand-Mediated Exocrinopathy Resembling Sjogren's Syndrome in Mice Transgenic for IL-10. J. Immunol. 162: 2488-2494 [Abstract] [Full Text]
Cavaillon, J.-M., Adib-Conquy, M., Marie, C., Fitting, C. (1999). Hyporesponsiveness in leukocytes in sepsis: in vitro models reveal paradoxical effects of IL-10. Innate Immunity 5: 81-85 [Abstract]
Balasa, B., Davies, J. D., Lee, J., Good, A., Yeung, B. T., Sarvetnick, N. (1998). IL-10 Impacts Autoimmune Diabetes Via a CD8+ T Cell Pathway Circumventing the Requirement for CD4+ T and B Lymphocytes. J. Immunol. 161: 4420-4427 [Abstract] [Full Text]
Begolka, W. S., Vanderlugt, C. L., Rahbe, S. M., Miller, S. D. (1998). Differential Expression of Inflammatory Cytokines Parallels Progression of Central Nervous System Pathology in Two Clinically Distinct Models of Multiple Sclerosis. J. Immunol. 161: 4437-4446 [Abstract] [Full Text]
Bettelli, E., Prabhu Das, M., Howard, E. D., Weiner, H. L., Sobel, R. A., Kuchroo, V. K. (1998). IL-10 Is Critical in the Regulation of Autoimmune Encephalomyelitis as Demonstrated by Studies of IL-10- and IL-4-Deficient and Transgenic Mice. J. Immunol. 161: 3299-3306 [Abstract] [Full Text]
Balasa, B., Deng, C., Lee, J., Christadoss, P., Sarvetnick, N. (1998). The Th2 Cytokine IL-4 Is Not Required for the Progression of Antibody-Dependent Autoimmune Myasthenia Gravis. J. Immunol. 161: 2856-2862 [Abstract] [Full Text]
Munder, M., Eichmann, K., Modolell, M. (1998). Alternative Metabolic States in Murine Macrophages Reflected by the Nitric Oxide Synthase/Arginase Balance: Competitive Regulation by CD4+ T Cells Correlates with Th1/Th2 Phenotype. J. Immunol. 160: 5347-5354 [Abstract] [Full Text]
Hammond, K. J.L., Poulton, L. D., Palmisano, L. J., Silveira, P. A., Godfrey, D. I., Baxter, A. G. (1998). alpha /beta -T Cell Receptor (TCR)+CD4-CD8- (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10. JEM 187: 1047-1056 [Abstract] [Full Text]
Groux, H., Bigler, M., de Vries, J. E., Roncarolo, M.-G. (1998). Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells. J. Immunol. 160: 3188-3193 [Abstract] [Full Text]
ASSEMAN, C, POWRIE, F (1998). Interleukin 10�is a growth factor for a population of regulatory T cells. Gut 42: 157-158 [Full Text]
Pakala, S. V., Kurrer, M. O., Katz, J. D. (1997). T Helper 2�(Th2) T Cells Induce Acute Pancreatitis and Diabetes in Immune-compromised Nonobese Diabetic (NOD) Mice. JEM 186: 299-306 [Abstract] [Full Text]
Mathisen, P. M., Yu, M., Johnson, J. M., Drazba, J. A., Tuohy, V. K. (1997). Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells. JEM 186: 159-164 [Abstract] [Full Text]
Kurrer, M.�O., Pakala, S.�V., Hanson, H.�L., Katz, J.�D. (1997). beta cell apoptosis in T cell-mediated�autoimmune�diabetes. Proc. Natl. Acad. Sci. USA 94: 213-218 [Abstract] [Full Text]
Katz, J., Benoist, C, Mathis, D (1995). T helper cell subsets in insulin-dependent diabetes. Science 268: 1185-1188 [Abstract]